Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.01 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |